Moderna (MRNA) PT Lowered to $40 at Barclays
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $64.52 +1.34%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Moderna (NASDAQ: MRNA) to $40.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
- Liftoff Mobile (LFTO) PT Lowered to $32 at Cantor Fitzgerald
- Jumia Technologies (JMIA) PT Lowered to $11 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
